Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust

investors.com/news/technology/moderna-stock-cmv-vaccine-fail

Moderna stock toppled Thursday after the biotech company's experimental CMV vaccine failed in a Phase 3 study of 7,500 women.
The post Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-10-23 14:05:59.
The Entire Business World on a Single Page. Free to Use →